IP Library Granted Patent US 12,297,425
Granted Patent B2
US 12,297,425 · App. 17/237,495 · Granted May 13, 2025

Nucleic acid extraction composition, reagent and kit containing the same and use thereof

Inventors: Xiang Chen (Beijing, CN); Lei Wang (Beijing, CN); Su Li (Beijing, CN); Longtang Zheng (Beijing, CN); Yanan Wang (Beijing, CN); Fei Wen (Beijing, CN); Juan Xin (Beijing, CN); Wentian Zhang (Beijing, CN); Jing Cheng (Beijing, CN)
Assignees: CAPITALBIO CORPORATION; WEST CHINA HOSPITAL OF SICHUAN UNIVERSITY
C12N15/1006C12Q1/6806
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,297,425
App. No.
17/237,495
Granted
May 13, 2025
Kind
B2
Abstract

A nucleic acid extraction composition, reagents and kits containing the same and uses thereof. Provided is a nucleic acid extraction and purification reagent free of volatile organic solvents, which prevents the damage of volatile organic solvents to people and greatly improves the timeliness of nucleic acid extraction and purification, making the operation extremely simple, and the nucleic acid can be obtained within 10 minutes. The obtained nucleic acid may be used for biological reactions such as PCR, NASBA, LAMP and RPA. Moreover, the reagents of the present disclosure may be used to extract nucleic acids of cells, bacteria, fungi, DNA viruses and RNA viruses from various samples such as blood, throat swab preserving fluid, saliva, urine, sputum, excrement and the like, and very suitable for clinical and scientific research uses.

Claims (13)

1. A nucleic acid extraction composition comprising a binding buffer, a wash buffer, a lysis buffer, an enhancer, and an elution buffer, wherein

the binding buffer is a composition comprising glycogen, 3-(Morpholin-4-yl)propane-1-sulfonic acid (MOPS), polyamine, and tris(2-carboxyethyl)phosphine (TCEP); the wash buffer is a composition comprising guanidine hydrochloride, potassium acetate, glycogen, MOPS, and polyamine;

in the binding buffer, the concentration of glycogen is 0.1% to 1% (m/v), the concentration of MOPS is 10 mM to 20 mM, the concentration of polyamine is 0.1% to 2% (m/v), and the concentration of TCEP is 5 mM to 50 mM; the polyamine comprises spermine, spermidine, butanediamine or a mixture thereof; and the pH of the binding buffer is 8.5 to 10;

in the wash buffer, the concentration of guanidine hydrochloride is 0.05 M to 0.6 M, the concentration of potassium acetate is 0.05 M to 0.5 M, the concentration of glycogen is 0.01% to 0.1% (m/v), the concentration of MOPS is 1 mM to 2 mM, and the concentration of polyamine is 0.01% to 0.3% (m/v); the polyamine comprises spermine, spermidine, butanediamine or a mixture thereof; and the pH of the wash buffer is 5 to 6;

the lysis buffer comprises guanidine isothiocyanate, 2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethanol or a mixture thereof; and in the lysis buffer, the concentration of guanidine isothiocyanate is 2 M to 8 M, the concentration of 2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethanol is 5% to 20% (v/v), and the pH value is 3 to 6;

the enhancer comprises proteinase K, trehalose, calcium chloride or a mixture thereof; and in the enhancer, the concentration of proteinase K is 10 mg/ml to 25 mg/ml, the concentration of trehalose is 3% to 12% (m/v), and the concentration of calcium chloride is 5 mM to 20 mM;

the elution buffer comprises sodium hydroxide, 1×Tris-EDTA (TE) buffer or a mixture thereof; the pH of 1×TE buffer in the elution buffer is adjusted to 8 to 10 with sodium hydroxide; and

the nucleic acid extraction composition does not comprise volatile organic solvents.

2. A kit for nucleic acid extraction or nucleic acid detection comprising the nucleic acid extraction composition according to claim 1 and a reagent or carrier acceptable for extraction and/or detection.

3. The kit according to claim 2 , wherein the carrier is selected from the group consisting of a silicon-based adsorption column, magnetic beads, glass beads, and a chitosan or silica modified carrier.

4. A method for nucleic acid extraction or detection for non-diagnostic purposes comprising

mixing a nucleic acid sample to be tested with the nucleic acid extraction composition according to claim 1 ; and

performing extraction and/or detection.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2025
From: CAPITALBIO CORPORATION; WEST CHINA HOSPITAL OF SICHUAN UNIVERSITY
To: CAPITALBIO CORPORATION; WEST CHINA HOSPITAL OF SICHUAN UNIVERSITY; TSINGHUA UNIVERSITY
Reel/Frame 073334/0987 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2021
From: CHEN, XIANG; WANG, LEI; LI, SU; ZHENG, LONGTANG; WANG, YANAN; WEN, FEI; XIN, JUAN; ZHANG, WENTIAN; CHENG, JING
To: CAPITALBIO CORPORATION; WEST CHINA HOSPITAL OF SICHUAN UNIVERSITY
Reel/Frame 056033/0826 →
Priority Claims (1)
CN 202010347016.5 · Apr 28, 2020 · national
Continuity (1)
Related Publication 20210332348A1 · Oct 28, 2021
References Cited (20)
US 7888006B2 · Lenz · 2011 [cited by applicant]
US 20190062802A1 · Boone et al. · 2019 [cited by applicant]
CN 101285062A · 2008 [cited by applicant]
CN 106085973A · 2016 [cited by applicant]
CN 106701741A · 2017 [cited by applicant]
CN 108774619A · 2018 [cited by applicant]
CN 109182332A · 2019 [cited by applicant]
CN 109207476A · 2019 [cited by applicant]
CN 109439656A · 2019 [cited by applicant]
CN 109722431A · 2019 [cited by applicant]
CN 110343601A · 2019 [cited by applicant]
CN 110452902A · 2019 [cited by applicant]
CN 110684764A · 2020 [cited by applicant]
EP 1529841A1 · 2005 [cited by applicant]
EP 1529840A1 · 2005 [cited by applicant]
TW 201213805A · 2012 [cited by applicant]
WO WO2004108741A1 · 2004 [cited by applicant]
WO WO2005012523A1 · 2005 [cited by applicant]
WO WO2013148346A1 · 2013 [cited by applicant]
Extended European Search Report in European Patent Application No. 21168496.4 issued Sep. 10, 2021. [cited by applicant]